Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 237

1.

"Why do you want your child to have braces?" Investigating the motivations of Hispanic/Latino and white parents.

Davis BB, Bayirli B, Ramsay DS, Turpin DL, Paige A, Riedy CA.

Am J Orthod Dentofacial Orthop. 2015 Nov;148(5):771-81. doi: 10.1016/j.ajodo.2015.05.023.

PMID:
26522037
2.

Obituary for George Randall Stirling (20.12.1927-30.11.2012).

Davis BB, Shardey GC.

Heart Lung Circ. 2013 Jun;22(6):490-1. No abstract available.

PMID:
23847787
3.

Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy.

Davis BB, Zeki AA, Bratt JM, Wang L, Filosto S, Walby WF, Kenyon NJ, Goldkorn T, Schelegle ES, Pinkerton KE.

Eur Respir J. 2013 Aug;42(2):350-61. doi: 10.1183/09031936.00042512. Epub 2012 Nov 22.

4.

A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARĪ³ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.

Xu DY, Davis BB, Wang ZH, Zhao SP, Wasti B, Liu ZL, Li N, Morisseau C, Chiamvimonvat N, Hammock BD.

Int J Cardiol. 2013 Aug 20;167(4):1298-304. doi: 10.1016/j.ijcard.2012.03.167. Epub 2012 Apr 21.

5.

Leukocytes are recruited through the bronchial circulation to the lung in a spontaneously hypertensive rat model of COPD.

Davis BB, Shen YH, Tancredi DJ, Flores V, Davis RP, Pinkerton KE.

PLoS One. 2012;7(3):e33304. doi: 10.1371/journal.pone.0033304. Epub 2012 Mar 21.

6.

Soluble epoxide hydrolase inhibitors and cardiovascular diseases.

Wang ZH, Davis BB, Jiang DQ, Zhao TT, Xu DY.

Curr Vasc Pharmacol. 2013 Jan;11(1):105-11. Review.

PMID:
22303912
7.

The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment.

Davis BB, Liu JY, Tancredi DJ, Wang L, Simon SI, Hammock BD, Pinkerton KE.

Biochem Biophys Res Commun. 2011 Jul 8;410(3):494-500. doi: 10.1016/j.bbrc.2011.06.008. Epub 2011 Jun 7.

8.

Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model.

Ulu A, Davis BB, Tsai HJ, Kim IH, Morisseau C, Inceoglu B, Fiehn O, Hammock BD, Weiss RH.

J Cardiovasc Pharmacol. 2008 Oct;52(4):314-23. doi: 10.1097/FJC.0b013e318185fa3c.

9.

Human leukocyte antigen mismatch and other factors affecting cryopreserved allograft valve function.

Yap CH, Skillington PD, Matalanis G, Davis BB, Tait BD, Hudson F, Ireland L, Nixon I, Yii M.

Heart Surg Forum. 2008;11(1):E42-5. doi: 10.1532/HSF98.20071104.

PMID:
18270140
10.

Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors.

Xu D, Li N, He Y, Timofeyev V, Lu L, Tsai HJ, Kim IH, Tuteja D, Mateo RK, Singapuri A, Davis BB, Low R, Hammock BD, Chiamvimonvat N.

Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18733-8. Epub 2006 Nov 27.

11.

Anti-HLA antibodies after cryopreserved allograft valve implantation does not predict valve dysfunction at three-year follow up.

Yap CH, Skillington PD, Matalanis G, Davis BB, Tait BD, Hudson F, Ireland L, Nixon I, Yiil M.

J Heart Valve Dis. 2006 Jul;15(4):540-4.

PMID:
16901051
12.

Indigenous health research: a critical review of outputs over time.

Sanson-Fisher RW, Campbell EM, Perkins JJ, Blunden SV, Davis BB.

Med J Aust. 2006 May 15;184(10):502-5.

PMID:
16719748
13.

Outcomes of coronary artery bypass grafting: a 3 year analysis using the Society of Thoracic Surgeons Database.

Smith JA, Mack JA, Rosenfeldt FL, Salamonsen RF, Davis BB, Rabinov M, Pick AW, Esmore DS.

Heart Lung Circ. 2000 May;9(1):5-8.

PMID:
16351986
14.

Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition.

Davis BB, Morisseau C, Newman JW, Pedersen TL, Hammock BD, Weiss RH.

J Pharmacol Exp Ther. 2006 Feb;316(2):815-21. Epub 2005 Oct 12.

15.

Clinical-pathologic conference in general thoracic surgery: Disseminated nocardiosis presenting as Pancoast syndrome.

Larobina M, McLean C, Davis BB.

J Thorac Cardiovasc Surg. 2004 Feb;127(2):568-71. No abstract available.

16.

Vascular localization of soluble epoxide hydrolase in the human kidney.

Yu Z, Davis BB, Morisseau C, Hammock BD, Olson JL, Kroetz DL, Weiss RH.

Am J Physiol Renal Physiol. 2004 Apr;286(4):F720-6. Epub 2003 Dec 9.

17.

Occlusive wrap dressing reduces infection rate in saphenous vein harvest site.

Rosenfeldt FL, Negri J, Holdaway D, Davis BB, Mack J, Grigg MJ, Miles C, Esmore DS.

Ann Thorac Surg. 2003 Jan;75(1):101-5; discussion 105.

PMID:
12537200
18.

Autoimmune myasthenia gravis: place of thymectomy and preferred technique.

Davis BB.

Intern Med J. 2003 Jan-Feb;33(1-2):58. No abstract available.

PMID:
12534885
19.

Overexpression of p73 causes apoptosis in vascular smooth muscle cells.

Davis BB, Dong Y, Weiss RH.

Am J Physiol Cell Physiol. 2003 Jan;284(1):C16-23. Epub 2002 Sep 18.

20.

Metabolism of N-acetylbenzidine and initiation of bladder cancer.

Zenser TV, Lakshmi VM, Hsu FF, Davis BB.

Mutat Res. 2002 Sep 30;506-507:29-40. Review.

PMID:
12351142
21.

Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.

Davis BB, Thompson DA, Howard LL, Morisseau C, Hammock BD, Weiss RH.

Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2222-7. Epub 2002 Feb 12. Erratum in: Proc Natl Acad Sci U S A 2002 Apr 2;99(7):4752.

22.

Methemoglobin oxidation of N-acetylbenzidine to form a sulfinamide.

Zenser TV, Lakshmi VM, Hsu FF, Davis BB.

Drug Metab Dispos. 2001 Apr;29(4 Pt 1):401-6.

23.

Reactive nitrogen oxygen species metabolize N-acetylbenzidine.

Lakshmi VM, Hsu FF, Davis BB, Zenser TV.

Chem Res Toxicol. 2001 Mar;14(3):312-8.

PMID:
11258981
24.

Nitrating reactive nitric oxygen species transform acetaminophen to 3-nitroacetaminophen.

Lakshmi VM, Hsu FF, Davis BB, Zenser TV.

Chem Res Toxicol. 2000 Sep;13(9):891-9.

PMID:
10995262
25.

N-Acetylbenzidine-DNA adduct formation by phorbol 12-myristate-stimulated human polymorphonuclear neutrophils.

Lakshmi VM, Hsu FF, Davis BB, Zenser TV.

Chem Res Toxicol. 2000 Aug;13(8):785-92.

PMID:
10956067
26.

Risk factors for surgical wound infection and bacteraemia following coronary artery bypass surgery.

Spelman DW, Russo P, Harrington G, Davis BB, Rabinov M, Smith JA, Spicer WJ, Esmore D.

Aust N Z J Surg. 2000 Jan;70(1):47-51.

PMID:
10696943
27.

Hypochlorous acid-mediated activation of N-acetylbenzidine to form N'-(3'-monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine.

Lakshmi VM, Hsu FF, McGarry AE, Davis BB, Zenser TV.

Toxicol Sci. 2000 Feb;53(2):202-12.

PMID:
10696768
28.

Sulfinamide formation following peroxidatic metabolism of N-acetylbenzidine.

Lakshmi VM, Hsu FF, Davis BB, Zenser TV.

Chem Res Toxicol. 2000 Feb;13(2):96-102.

PMID:
10688533
29.

Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides.

Ciotti M, Lakshmi VM, Basu N, Davis BB, Owens IS, Zenser TV.

Carcinogenesis. 1999 Oct;20(10):1963-9.

PMID:
10506112
31.

Peroxygenase metabolism of N-acetylbenzidine by prostaglandin H synthase. Formation of an N-hydroxylamine.

Zenser TV, Lakshmi VM, Hsu FF, Davis BB.

J Biol Chem. 1999 May 21;274(21):14850-6.

32.

Clonidine and cardiac surgery: haemodynamic and metabolic effects, myocardial ischaemia and recovery.

Myles PS, Hunt JO, Holdgaard HO, McRae R, Buckland MR, Moloney J, Hall J, Bujor MA, Esmore DS, Davis BB, Morgan DJ.

Anaesth Intensive Care. 1999 Apr;27(2):137-47.

33.

N-glucuronidation of benzidine and its metabolites. Role in bladder cancer.

Zenser TV, Lakshmi VM, Davis BB.

Drug Metab Dispos. 1998 Sep;26(9):856-9. Review.

34.

N'-(3'-monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine formation by peroxidative metabolism.

Lakshmi VM, Zenser TV, Davis BB.

Carcinogenesis. 1998 May;19(5):911-7.

PMID:
9635882
35.

"Low SVR syndrome" or SIRS after cardiac operations?

Myles PS, Davis BB.

Ann Thorac Surg. 1998 Jan;65(1):298. No abstract available.

PMID:
9456150
36.

Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers.

Rothman N, Talaska G, Hayes RB, Bhatnagar VK, Bell DA, Lakshmi VM, Kashyap SK, Dosemeci M, Kashyap R, Hsu FF, Jaeger M, Hirvonen A, Parikh DJ, Davis BB, Zenser TV.

Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1039-42.

37.

Urinary mutagenicity as a biomarker in workers exposed to benzidine: correlation with urinary metabolites and urothelial DNA adducts.

DeMarini DM, Brooks LR, Bhatnagar VK, Hayes RB, Eischen BT, Shelton ML, Zenser TV, Talaska G, Kashyap SK, Dosemeci M, Kashyap R, Parikh DJ, Lakshmi V, Hsu F, Davis BB, Jaeger M, Rothman N.

Carcinogenesis. 1997 May;18(5):981-8.

PMID:
9163684
38.

Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine.

Lakshmi VM, Zenser TV, Davis BB.

Drug Metab Dispos. 1997 Apr;25(4):481-8.

39.

Hemodynamic effects, myocardial ischemia, and timing of tracheal extubation with propofol-based anesthesia for cardiac surgery.

Myles PS, Buckland MR, Weeks AM, Bujor MA, McRae R, Langley M, Moloney JT, Hunt JO, Davis BB.

Anesth Analg. 1997 Jan;84(1):12-9.

PMID:
8988992
40.

The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.

Rothman N, Hayes RB, Zenser TV, DeMarini DM, Bi W, Hirvonen A, Talaska G, Bhatnagar VK, Caporaso NE, Brooks LR, Lakshmi VM, Feng P, Kashyap SK, You X, Eischen BT, Kashyap R, Shelton ML, Hsu FF, Jaeger M, Parikh DJ, Davis BB, Yin S, Bell DA.

Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):979-83.

41.

NADPH-dependent oxidation of benzidine by rat liver.

Lakshmi VM, Zenser NT, Hsu FF, Mattammal MB, Zenser TV, Davis BB.

Carcinogenesis. 1996 Sep;17(9):1941-7.

PMID:
8824518
42.

Human N-acetylation of benzidine: role of NAT1 and NAT2.

Zenser TV, Lakshmi VM, Rustan TD, Doll MA, Deitz AC, Davis BB, Hein DW.

Cancer Res. 1996 Sep 1;56(17):3941-7.

43.

Glucuronide conjugates of 4-aminobiphenyl and its N-hydroxy metabolites. pH stability and synthesis by human and dog liver.

Babu SR, Lakshmi VM, Huang GP, Zenser TV, Davis BB.

Biochem Pharmacol. 1996 Jun 28;51(12):1679-85.

PMID:
8687483
44.

The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers.

Rothman N, Bhatnagar VK, Hayes RB, Zenser TV, Kashyap SK, Butler MA, Bell DA, Lakshmi V, Jaeger M, Kashyap R, Hirvonen A, Schulte PA, Dosemeci M, Hsu F, Parikh DJ, Davis BB, Talaska G.

Proc Natl Acad Sci U S A. 1996 May 14;93(10):5084-9.

45.

Dissection of an allograft ascending aorta after aortic root replacement.

Smith JA, McKenzie TC, Davis BB.

Ann Thorac Surg. 1996 Mar;61(3):1011-2.

PMID:
8619675
46.

Glucuronidation of N-hydroxy metabolites of N-acetylbenzidine.

Babu SR, Lakshmi VM, Hsu FF, Zenser TV, Davis BB.

Carcinogenesis. 1995 Dec;16(12):3069-74.

PMID:
8603487
47.

Improved preservation of saphenous vein grafts by the use of glyceryl trinitrate-verapamil solution during harvesting.

Roubos N, Rosenfeldt FL, Richards SM, Conyers RA, Davis BB.

Circulation. 1995 Nov 1;92(9 Suppl):II31-6.

PMID:
7586430
48.

N-acetylbenzidine and N,N'-diacetylbenzidine formation by rat and human liver slices exposed to benzidine.

Lakshmi VM, Bell DA, Watson MA, Zenser TV, Davis BB.

Carcinogenesis. 1995 Jul;16(7):1565-71.

PMID:
7614690
49.

The role of acetylation in benzidine metabolism and DNA adduct formation in dog and rat liver.

Lakshmi VM, Zenser TV, Goldman HD, Spencer GG, Gupta RC, Hsu FF, Davis BB.

Chem Res Toxicol. 1995 Jul-Aug;8(5):711-20.

PMID:
7548754
50.

Comparison of patient-controlled analgesia and nurse-controlled infusion analgesia after cardiac surgery.

Myles PS, Buckland MR, Cannon GB, Bujor MA, Langley M, Breaden A, Salamonsen RF, Davis BB.

Anaesth Intensive Care. 1994 Dec;22(6):672-8.

PMID:
7892970

Supplemental Content

Loading ...
Support Center